Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
5-year outcomes of iStent micro-bypass vs. Kahook dual blade goniotomy in open angle glaucoma.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ansari Ejaz
Аннотация
PURPOSE: Long-term comparison of efficacy and safety of i-Stent versus KDB goniotomy combined with phacoemulsification through to 5 years.
METHODS: A retrospective chart review of 88 patients that received iStent or KDB in combination with phacoemulsification at a single centre between January 2014 and January 2019. Outcome measures were proportion of eyes achieving ≥ 20% reduction of IOP, drop dependence through to 5 years and change in visual field mean deviation (MD) at year 5 compared to baseline. Early to moderate stage of glaucoma.
RESULTS: No significant difference between groups for IOP reduction (p = 0.3) or visual field MD (p = 0.85) at all time points through to 5 years. Significantly lower drop dependence favouring KDB at all time points (p < 0.001 year 1; p = 0.02 year 5). Lower rate of secondary procedures following KDB (7.7% vs. 14% p = 0.48). Adverse events following iStent and KDB: hyphaema (5.5% v 10% p = 0.70), corneal oedema (8% v 2% p = 0.30), rebound anterior uveitis (5.5% v 2% p = 0.57). Complications resolved within 2 weeks with no serious incidents (loss of VA by ≥ 2 Snellen lines/ 0.3 logMAR).
CONCLUSION: Each procedure provided comparable long-term IOP reduction and visual field stability over five years. KDB goniotomy resulted in significantly less drop dependence throughout with fewer associated secondary procedures. Adverse events were infrequent and mild, with no serious complications observed.
METHODS: A retrospective chart review of 88 patients that received iStent or KDB in combination with phacoemulsification at a single centre between January 2014 and January 2019. Outcome measures were proportion of eyes achieving ≥ 20% reduction of IOP, drop dependence through to 5 years and change in visual field mean deviation (MD) at year 5 compared to baseline. Early to moderate stage of glaucoma.
RESULTS: No significant difference between groups for IOP reduction (p = 0.3) or visual field MD (p = 0.85) at all time points through to 5 years. Significantly lower drop dependence favouring KDB at all time points (p < 0.001 year 1; p = 0.02 year 5). Lower rate of secondary procedures following KDB (7.7% vs. 14% p = 0.48). Adverse events following iStent and KDB: hyphaema (5.5% v 10% p = 0.70), corneal oedema (8% v 2% p = 0.30), rebound anterior uveitis (5.5% v 2% p = 0.57). Complications resolved within 2 weeks with no serious incidents (loss of VA by ≥ 2 Snellen lines/ 0.3 logMAR).
CONCLUSION: Each procedure provided comparable long-term IOP reduction and visual field stability over five years. KDB goniotomy resulted in significantly less drop dependence throughout with fewer associated secondary procedures. Adverse events were infrequent and mild, with no serious complications observed.